NIH-funded research R01 grant

Improving gene editing techniques for treating neurological diseases

Official title: Advanced Delivery Platforms for Base Editing In Vivo

Funded at Univ of Massachusetts Med Sch Worcester · NIH-10912556 · Data updated 2026-11-12

This study is testing a new way to improve gene editing for brain and nervous system conditions using a special tool called Nme2Cas9, which helps make precise changes in genes while aiming to keep side effects low and treatment safe.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$583,738
NIH project number5R01GM150273-02
Project IDNIH-10912556 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic disorders affecting the central nervous system, such as Amyotrophic Lateral Sclerosis or Batten Disease.

Less likely to help

Patients with conditions unrelated to genetic mutations or those not affecting the central nervous system may not benefit from this research.

What this research studies

This research focuses on enhancing gene editing methods using a novel platform called Nme2Cas9, which allows for precise alterations in the genome. By utilizing adeno-associated viruses (AAV) for delivery, the project aims to improve the efficiency and safety of base editing in vivo, particularly for conditions affecting the central nervous system. The researchers will validate these advanced editing systems in mouse models of CNS diseases, aiming to minimize side effects and enhance therapeutic outcomes.

Why it matters

Potential benefit: If successful, this research could lead to more effective and safer treatments for neurological diseases caused by genetic mutations.

How similar studies have gone: Previous research has shown promise in using CRISPR-based approaches for gene editing, indicating potential success for this novel method.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Sontheimer, Erik J. — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Sontheimer, Erik J.

Related research

Other NIH-funded projects on the same topics.

  • Understanding HIV-1 Env shapes to boost immune attack against infected cells

    Aimed at helping people living with HIV, this project explores how specific HIV-1 envelope structures attract or resist immune attack so future therapies could better help the body clear hidden virus.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11620068

  • Reprogramming metabolism to power alternative fat-burning modes

    A new project will explore how fat cells burn calories in different ways to help combat obesity.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11607804

  • Silencing an Extra Chromosome to Help Down Syndrome and Related Conditions

    A patient-friendly plan to use a gene-based approach to quiet an extra chromosome in cells and a mouse model to reduce disease-related effects in Down syndrome and other chromosomal imbalance disorders.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11600903

  • Gut microbes and brain function in autism

    Researchers are exploring how gut bacteria may influence brain signals and behavior in autism, using worm models to uncover possible links that could someday inform human therapies.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11594150

  • Chlamydia and gonorrhea interaction: how host interferons influence co-infection

    A human-health focused project looks at how the body’s interferon signals during chlamydia infection affect the way gonorrhea behaves, with potential implications for people vulnerable to both infections.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11572329

  • Conquering High Blood Pressure in Vietnamese Cities

    A program to adapt and test a proven plan for lowering high blood pressure in urban Vietnam using a mobile health platform and integrated care approach.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11565070

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.